AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 283: H264-H272, 2002. First published February 7, 2002; doi:10.1152/ajpheart.00505.2001
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/H264    most recent
00505.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goette, A.
Right arrow Articles by Lendeckel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goette, A.
Right arrow Articles by Lendeckel, U.
Vol. 283, Issue 1, H264-H272, July 2002

Calpains and cytokines in fibrillating human atria

Andreas Goette1, Marco Arndt2, Christoph Röcken3, Thorsten Staack1, Roland Bechtloff1, Dirk Reinhold5, Christof Huth4, Siegfried Ansorge2, Helmut U. Klein1, and Uwe Lendeckel2

1 Division of Cardiology, Department of Internal Medicine, 2 Institute of Experimental Internal Medicine, 3 Institute of Pathology, 4 Department of Cardiovascular Surgery, and 5 Institute of Immunology, University Hospital Magdeburg, 39120 Magdeburg, Germany

Atrial fibrillation (AF) is accompanied by intracellular calcium overload. The purpose of this study was to assess the role of calcium-dependent calpains and cytokines during AF. Atrial tissue samples from 32 patients [16 with chronic AF and 16 in sinus rhythm (SR)] undergoing open heart surgery were studied. Atrial expression of calpain I and II, calpastatin, troponin T (TnT), troponin C (TnC), and cytokines [interleukin (IL)-1beta , IL-2, IL-6, IL-8, IL-10, transforming growth factor (TGF)-beta 1, and tumor necrosis factor-alpha ] were determined. Expression of calpain I was increased during AF (461 ± 201% vs. 100 ± 34%, P < 0.05). Amounts of calpain II and calpastatin were unchanged. Total calpain enzymatic activity was more than doubled during AF (35.2 ± 17.7 vs. 12.4 ± 9.2 units, P < 0.05). In contrast to TnC, TnT levels were reduced in fibrillating atria by 26% (P < 0.05), corresponding to the myofilament disintegration seen by electron microscopy. Small amounts of only IL-2 and TGF-beta 1 mRNA and protein were detected regardless of the underlying cardiac rhythm. In conclusion, atria of patients with permanent AF show evidence of calpain I activation that might contribute to structural remodeling and contractile dysfunction, whereas there is no evidence of activation of tissue cytokines.

fibrillation; calcium; contractile proteins; cytokine; inflammation


This article has been cited by other articles:


Home page
EuropaceHome page
I. Liuba, H. Ahlmroth, L. Jonasson, A. Englund, A. Jonsson, K. Safstrom, and H. Walfridsson
Source of inflammatory markers in patients with atrial fibrillation
Europace, July 1, 2008; 10(7): 848 - 853.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Dobrev and E. Wettwer
Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis
Cardiovasc Res, June 1, 2008; 78(3): 411 - 412.
[Full Text] [PDF]


Home page
Circ Arrhythmia ElectrophysiolHome page
S. Nattel, B. Burstein, and D. Dobrev
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 62 - 73.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. W. Lee, T. H. Everett IV, D. Rahmutula, J. M. Guerra, E. Wilson, C. Ding, and J. E. Olgin
Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure
Circulation, October 17, 2006; 114(16): 1703 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Goette and U. Schotten
Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation
Eur. Heart J., September 1, 2006; 27(17): 2034 - 2035.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Anne, R. Willems, T. Roskams, P. Sergeant, P. Herijgers, P. Holemans, H. Ector, and H. Heidbuchel
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation
Cardiovasc Res, September 1, 2005; 67(4): 655 - 666.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Hanna, S. Cardin, T.-K. Leung, and S. Nattel
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure
Cardiovasc Res, August 1, 2004; 63(2): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. G. Conway, P. Buggins, E. Hughes, and G. Y. H. Lip
Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2075 - 2082.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Wasson, H. K. Reddy, and M. L. Dohrmann
Current Perspectives of Electrical Remodeling and Its Therapeutic Implications
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
S. Cardin, D. Li, N. Thorin-Trescases, T.-K. Leung, E. Thorin, and S. Nattel
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways
Cardiovasc Res, November 1, 2003; 60(2): 315 - 325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online